A heatmap analysis reveals that the expression of CDH1 is upregulated in breast, bladder, colon, lung, renal, and thyroid cancer, including prostate cancer, while in adrenal cancer and acute myeloid leukemia (AML), there is no change in the expression of the CDH1 gene. This evidence concerns the gene CDH1 and prostate carcinoma.